Blood Glucose Test Strips or Diabetes Test Strips, helping people to monitor their Glucose level and control their diabetes have come a long way since the day of invention. From a dye-based technology to base on electrochemical technology, totally digitalized and from one test strip to glucose plus blood ketone tests, combo test strips. Growing prevalence of diabetes coupled with the important role these strips play in keeping a tab on diabetes levels; drive the demand for these strips in multiplication. Obviously, the market of Blood Glucose Test Strips is ever increasing, flooding with the various brands of blood glucose test strips, floating in the space. Each brand having their own technology & design, spend increasingly on R&D activities to perfect the product. This, in turn, is paying off well & increasing the market size, elevating it on the global platform. Acknowledging the exponential growth, the market perceives currently and gauging the potential the market holds to grow in the future; Market Research Future (MRFR), in its recently published market forecast asserts that the Global Blood Glucose Test Strip Market will grow exponentially by 2027, registering a striking CAGR throughout the forecast period (2017 – 2027). Blood Glucose Test Strip Market – Key Players Some of the key players for Blood Glucose Test Strip Market are:
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/892 Blood Glucose Test Strip Market – Segments The Blood Glucose Test Strip Market can be segmented in to 2 key dynamics for the convenience of the report and enhanced understanding; By Technologies: Comprises Thick Film Electrochemical, Thin Film Electrochemical, & Optical among others By Regions: North America, Europe, APAC and Rest of the World. Industry, Innovation & Related News: July 05, 2018 – Researchers at MIT’s Little Devices Lab (US) presented a Lego-like device they have developed to perform diagnostic tests at a fraction of the cost of traditional methods. Referred to as “plug-and-play” the engineered system device is called as Ampli blocks, can test blood glucose levels in diabetic patients and also detect viral infection. June 22, 2018 – The U.S. Food and Drug Administration (FDA) approved a mHealth platform that includes a sensor embedded in the arm, a wearable transmitter and an app, all designed to help those with diabetes and their care teams continuously track blood-glucose levels. The Eversense CGM, system useful in continuous glucose management is developed by Senseonics and accounts for the first approved implantable device that promises up to three months of constant monitoring, contrary to other wearable CGM platforms. April 13, 2018 – Livongo Health (US) a start-up developing connected devices and software for diabetics and other chronic conditions. The company completely devoted to providing cost-competitive aid for diabetes, has already developed its own glucometer & apps providing accurate readings. Livongo, also ships test strips to patients at no additional cost. The company announced that it has bagged the investment for USD 105 million to support the further development of its technology and a partnership from Cambia Health Solution. April 2018 Pops! Diabetes Care, which is a Twin Cities device maker has registered its first patient in their clinical study which it is backing to see whether their device named, Pops! One, can effectively monitor blood-sugar levels for diabetics. They are also additionally partnering with the Children’s Minnesota health care system on a six-month research of 50 young patients who have been diagnosed with type 1 diabetes. They will use the Pops device to record their blood-glucose levels and alert them when they need to inject insulin. The most noticeable piece is the blood-testing device which is slightly smaller than a typical smartphone which contains a disposable cartridge with a glucose meter and three tiny lancets that have been designed so that they are less painful and easier than using a conventional finger-stick unit with individual test strips. The individual replacement cartridge can be used for up to three tests. Blood Glucose Test Strip Market – Regional Analysis North America market leads the Global Blood Glucose Test Strip Market with the significant market share. The market is further expected to reach astronomical amounts growing at a substantial CAGR throughout the forecast period (2017-2027). Well-developed healthcare sector, increasing prevalence of diabetes in the U.S. & Canada coupled with the high per capita healthcare expenditures of these economies, together drive the regional market growth. Moreover, presence of some of the matured market players fuels the market growth. Europe & Asia Pacific is the second & third largest market respectively in the Global Blood Glucose Test Strip Market. Expected to be a fastest growing market Asia pacific region is estimated to grow rapidly over the projected period. Increasing healthcare expenditures along with favorable government policies of developing economies like India and China foster the market growth in APAC. Browse Complete 110 Pages Premium Research Report Enabled with Tables and Figures @ https://www.marketresearchfuture.com/reports/blood-glucose-test-strip-market-892 While the world’s second largest market of Blood Glucose Test Strip, Europe is predominantly driven by the availability of funds for research, well-developed healthcare infrastructure, huge patient population, & government support for research & development. Besides, economies having high healthcare expenditures such as the UK & Germany propel the growth of the Europe market. About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.